Company Filing History:
32 out of 197 
14 out of 306 
1 out of 6 Years Active: 1978-1998
Title: Karl-Heinz Weber: A Pioneering Inventor with 47 Patents
Introduction:
In the world of innovation and patents, prolific inventors drive advancements in various fields. One such notable individual is Karl-Heinz Weber, hailing from Gau-Algesheim, Germany. With an impressive portfolio of 47 patents, Weber has left an indelible mark on the pharmaceutical industry. Let's delve into his latest patents, career highlights, collaborations, and celebrate his contributions to the field of innovation.
Latest Patents:
Karl-Heinz Weber has recently secured two groundbreaking patents that have the potential to revolutionize the world of pharmaceuticals. The first patent involves acylamino-substituted hetrazepines. These compounds and the pharmaceutical compositions containing them are specifically designed to treat diseases in warm-blooded animals triggered by endogenously formed PAF (platelet-activating factor). The patent focuses on a hetrazepine formula that exhibits PAF-inhibitory properties, thus offering promising therapeutic applications for various ailments.
Weber's second patent centers around hetrazepinoid amides, more specifically, thienodiazepines. This invention encompasses the synthesis of novel thienodiazepines, represented by Formula Ib. The patent also includes the development of processes for preparing these thienodiazepines and their potential use in pharmaceutical compositions with PAF-antagonistic activity. These inventions demonstrate Weber's commitment to advancing medical treatments through innovative chemical compounds.
Career Highlights:
Karl-Heinz Weber's illustrious career has spanned several reputable companies. He has made significant contributions to the success of Boehringer Ingelheim KG and Boehringer Ingelheim GmbH. Boehringer Ingelheim, a global pharmaceutical company with a rich history, recognizes Weber's talent and dedication to innovation. Throughout his tenure, Weber has showcased exemplary expertise in the field of medicinal chemistry, earning him a distinguished reputation.
Collaborations:
Innovation often thrives through collaboration, and Karl-Heinz Weber has had the opportunity to work alongside distinguished colleagues during his career. Notably, he has collaborated with Gerhard Walther and Claus S. Schneider. Through these collaborations, Weber has shared knowledge, exchanged ideas, and contributed to joint inventions, fostering a culture of innovation in the pharmaceutical industry.
Conclusion:
Karl-Heinz Weber stands as a shining example of an inventor committed to advancing medical treatments through his patented pharmaceutical compounds. With an impressive track record of 47 patents, including his recent breakthrough inventions in acylamino-substituted hetrazepines and hetrazepinoid amides, Weber has made a significant impact on the field of medicinal chemistry. His collaboration with esteemed coworkers such as Gerhard Walther and Claus S. Schneider further highlights his commitment to pushing the boundaries of innovation.
As we celebrate Karl-Heinz Weber's achievements, it is clear that his contributions to the pharmaceutical industry will continue to impact the lives of many. Through his dedication to creating novel compounds and his collaborations, Weber has significantly advanced the field of medicine. We look forward to witnessing more groundbreaking patents from this esteemed inventor in the future.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.